Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06375044 · RECRUITING
Trial details
- NCT number
- NCT06375044
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-24
- Primary completion
- 2027-09-30
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.